Regeneron’s experimental gene therapy improves hearing in one patient

May 8 (Reuters) – Regeneron Pharmaceuticals said on Wednesday its investigational gene therapy improved hearing to normal levels in a child within 24 weeks in an early to mid-stage study. (Reporting by Bhanvi Satija in Bengaluru; Editing by Shounak Dasgupta)

(c) Copyright Thomson Reuters 2024. Click For Restrictions – https://agency.reuters.com/en/copyright.html